SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+162.2%
5Y CAGR+46.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+162.2%/yr
Quarterly compound
5Y CAGR
+46.1%/yr
Recent acceleration
Percentile
P85
Within normal range
vs 5Y Ago
6.7x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 20.65% |
| Q3 2025 | -0.15% |
| Q2 2025 | -45.20% |
| Q1 2025 | -18.58% |
| Q4 2024 | 2.74% |
| Q3 2024 | 9.04% |
| Q2 2024 | 21.38% |
| Q1 2024 | -14.08% |
| Q4 2023 | 2.92% |
| Q3 2023 | 2.82% |
| Q2 2023 | 18.92% |
| Q1 2023 | -10.55% |
| Q4 2022 | 1.14% |
| Q3 2022 | 6.45% |
| Q2 2022 | 35.97% |
| Q1 2022 | -19.05% |
| Q4 2021 | 1.42% |
| Q3 2021 | 0.96% |
| Q2 2021 | 35.47% |
| Q1 2021 | -17.39% |
| Q4 2020 | 3.10% |
| Q3 2020 | 19.25% |
| Q2 2020 | 6.80% |
| Q1 2020 | -17.12% |
| Q4 2019 | 3.55% |
| Q3 2019 | -5.41% |
| Q2 2019 | 54.40% |
| Q1 2019 | -29.14% |
| Q4 2018 | 11.38% |
| Q3 2018 | 1.81% |
| Q2 2018 | 18.08% |
| Q1 2018 | -0.37% |
| Q4 2017 | -8.14% |
| Q3 2017 | 9.65% |
| Q2 2017 | 135.46% |
| Q1 2017 | -454.80% |
| Q4 2016 | -25.05% |
| Q3 2016 | 9.94% |
| Q2 2016 | 149.98% |
| Q1 2016 | -371.71% |